Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT05563389
PHASE2/PHASE3
Statin Impact on Hepatic Decompensation
Sponsor: Tanta University
View on ClinicalTrials.gov
Summary
The study aims to evaluate the impact of statin on hepatic decompensation.
Official title: the Impact of Statin on Cirrhotic Patients
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2022-06-15
Completion Date
2023-02-25
Last Updated
2026-09-14
Healthy Volunteers
No
Interventions
DRUG
Atorvastatin 20mg
active arm
DRUG
Placebo
placebo arm
Locations (1)
Tanta University
Tanta, Egypt